These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15678597)

  • 1. Applying toxicogenomics in mechanistic and predictive toxicology.
    Cunningham ML; Lehman-McKeeman L
    Toxicol Sci; 2005 Feb; 83(2):205-6. PubMed ID: 15678597
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicogenomics in predictive toxicology in drug development.
    Suter L; Babiss LE; Wheeldon EB
    Chem Biol; 2004 Feb; 11(2):161-71. PubMed ID: 15123278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenomics and clinical toxicology: an example of the connection between basic and applied sciences.
    Ferrer-Dufol A; Menao-Guillen S
    Toxicol Lett; 2009 Apr; 186(1):2-8. PubMed ID: 19027838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicogenomics in the assessment of immunotoxicity.
    Baken KA; Vandebriel RJ; Pennings JL; Kleinjans JC; van Loveren H
    Methods; 2007 Jan; 41(1):132-41. PubMed ID: 17161310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of bioinformatics in toxicology: advancing toxicogenomics.
    Afshari CA; Hamadeh HK; Bushel PR
    Toxicol Sci; 2011 Mar; 120 Suppl 1(Suppl 1):S225-37. PubMed ID: 21177775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA microarrays as a tool in toxicogenomics.
    de Longueville F; Bertholet V; Remacle J
    Comb Chem High Throughput Screen; 2004 May; 7(3):207-11. PubMed ID: 15134526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicogenomics applied to predictive and exploratory toxicology for the safety assessment of new chemical entities: a long road with deep potholes.
    Pognan F
    Prog Drug Res; 2007; 64():217, 219-38. PubMed ID: 17195477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk prediction: individualized variability in susceptibility to toxicants.
    Nebert DW; Zhang G; Vesell ES
    Annu Rev Pharmacol Toxicol; 2013; 53():355-75. PubMed ID: 23294311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in applying genomics in drug development.
    Lord PG
    Toxicol Lett; 2004 Apr; 149(1-3):371-5. PubMed ID: 15093283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Japanese toxicogenomics project: application of toxicogenomics.
    Uehara T; Ono A; Maruyama T; Kato I; Yamada H; Ohno Y; Urushidani T
    Mol Nutr Food Res; 2010 Feb; 54(2):218-27. PubMed ID: 20041446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicomicrobiomics: Narrowing the Gap Between Environmental and Medicinal Toxicogenomics.
    Aziz RK
    OMICS; 2018 Dec; 22(12):788-789. PubMed ID: 30571608
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicogenomics: transcription profiling for toxicology assessment.
    Zhou T; Chou J; Watkins PB; Kaufmann WK
    EXS; 2009; 99():325-66. PubMed ID: 19157067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of toxicogenomics in drug safety evaluation: Current status and an industry perspective.
    Vahle JL; Anderson U; Blomme EAG; Hoflack JC; Stiehl DP
    Regul Toxicol Pharmacol; 2018 Jul; 96():18-29. PubMed ID: 29679677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenomics in drug development: a match made in heaven?
    Qin C; Tanis KQ; Podtelezhnikov AA; Glaab WE; Sistare FD; DeGeorge JJ
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):847-9. PubMed ID: 27050123
    [No Abstract]   [Full Text] [Related]  

  • 15. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future applications of toxicogenomics: Results summary of a survey from the HESI Genomics State of Science Subcommittee.
    Pettit S; des Etages SA; Mylecraine L; Snyder R; Fostel J; Dunn RT; Haymes K; Duval M; Stevens J; Afshari C; Vickers A
    Environ Health Perspect; 2010 Jul; 118(7):992-7. PubMed ID: 20100679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying knowledge-driven mechanistic inference to toxicogenomics.
    Tripodi IJ; Callahan TJ; Westfall JT; Meitzer NS; Dowell RD; Hunter LE
    Toxicol In Vitro; 2020 Aug; 66():104877. PubMed ID: 32387679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
    Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
    Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncoding RNA response to xenobiotic exposure: an indicator of toxicity and carcinogenicity.
    Marrone AK; Beland FA; Pogribny IP
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1409-22. PubMed ID: 25171492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.